Report Outlines the Realities of Asthma Care in the United States and the Policy and Clinical Interventions that May Provide Improvements to Current Asthma Care ...

AstraZeneca's checkpoint inhibitor Imfinzi ... Aiwu Ruth He of Medstar Georgetown University Hospital in Washington DC. "The combination of durvalumab and chemotherapy should become a new standard ...

AstraZeneca said it is doubling down on its investment in its U.S. business. Meanwhile, General Catalyst has agreed to ...

CAMBRIDGE, Britain — CAMBRIDGE, Britain — Astrazeneca PLC (AZN) on Tuesday reported third-quarter earnings of $1.43 billion. On a per-share basis, the Cambridge, Britain-based company said it ...

LONDON — AstraZeneca said Tuesday it has had to resubmit a closely watched medicine for U.S. approval in a different form of ...

Cambridge, England-based biopharmaceutical giant AstraZeneca is pouring billions of dollars into properties in the United ...

AstraZeneca shared the topline result from the placebo-controlled trial in a press release Tuesday. NF1 affects around 1.7 million people worldwide, with about 70% being adults, according to ...

LONDON, Nov 12 (Reuters) - London-listed drugmaker AstraZeneca (AZN.L), opens new tab said its plan to invest 450 million pounds ($576.7 million) in Britain for vaccine research and development ...

British drugmaker AstraZeneca increased its full-year sales outlook on booming demand for its cancer and rare-disease drugs, and said it plans to invest $3.5 billion in its U.S. business by the ...

AstraZeneca CEO Pascal Soriot argued that the company did not lose oversight. “You really cannot police 18,000 people from the headquarter,” Soriot said during a press call Tuesday ...